We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HHS AWARDS VAXGEN CONTRACT FOR ANTHRAX VACCINE
HHS AWARDS VAXGEN CONTRACT FOR ANTHRAX VACCINE
November 5, 2004
VaxGen has been awarded an $877.5 million contract from HHS to develop, test and manufacture enough new anthrax vaccine to inoculate millions of Americans in the event of a bioterrorist attack using inhalation anthrax.